The implications of cost-effectiveness analysis of medical technology. Background paper number 2: case studies of medical technologies. Case study number 13: cardiac radionuclide imaging and cost effectiveness
Cardiac radionuclide imaging is a new and rapidly expanding diagnostic technology that promises to make significant contributions to the diagnosis and management of heart disease. Dynamic changes are occurring in the technology at the same time diffusion is taking place. The combination of diffusion and technological development creates an imperative for careful evaluation and prospective planning. Clinical applications of cardiac imaging include the diagnosis of coronary artery disease, evaluation of cardiac function abnormalities, verification of the diagnosis of acute myocardial infarction (heart attack), and monitoring of patients under treatment for establishing cardiac disease. The report describes the dimensions of the technology of cardiac radionuclide imaging. Information is summarized on the industry producing radionuclide imaging equipment, on clinical applications of technology, and on the costs and efficacies of the various techniques. Finally, formulation of some of the issues involved in the assessment of the technology's cost effectiveness is presented.
- Research Organization:
- Office of Technology Assessment (U.S. Congress), Washington, DC
- OSTI ID:
- 6492836
- Report Number(s):
- PB-82-239989
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radionuclide methods in the assessment of left ventricular function
Prognostic value and limitations of exercise radionuclide angiography in medically treated coronary artery disease